Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trialRenaud Felten, Jacques‐Eric Gottenberg, P. Duffau et al.|Annals of the Rheumatic Diseases|2020Cited by 107
Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014‐04 (Etoile du Nord) trialEileen M. Boyle, Xavier Leleu, Marie‐Odile Petillon et al.|British Journal of Haematology|2019Cited by 23